Dr. Kenneth Ramos Named 2025 Texas A&M University Distinguished Professor
Dr. Kenneth S. Ramos, executive director of the Institute of Biosciences and Technology (IBT) at Texas A&M University and director of the Center for Genomic and Precision Medicine, has been named a 2025 Texas A&M University Distinguished Professor, one of the highest honors the University bestows on faculty.
A Career Defined by Precision Medicine
Distinguished Professor is reserved for faculty whose scholarship, teaching, and service have achieved national and international distinction. For Dr. Ramos, the honor recognizes a body of work that has helped shape how genomic science is translated into clinical practice.
At IBT, Dr. Ramos leads an institute positioned in the heart of the Texas Medical Center, where interdisciplinary collaboration is a daily practice. His leadership has strengthened connections between basic science, clinical research, and the training of the next generation of biomedical investigators.
Advancing Genomic and Precision Medicine
Through the Center for Genomic and Precision Medicine, Dr. Ramos has championed research that moves beyond one-size-fits-all treatment toward therapies tailored to a patient's genetic and molecular profile. That vision aligns with Texas A&M University's broader commitment to improving human and animal health through rigorous science and purposeful innovation.
Dr. Ramos brings a combination of scientific depth and institutional leadership, mentoring faculty and trainees while building partnerships that extend IBT's reach across Texas A&M University Health and the broader research community.
What This Means for IBT
The Distinguished Professor designation elevates the visibility of IBT and underscores the caliber of research happening in Houston. For students, trainees, and faculty recruits, it signals that IBT is home to nationally recognized leadership in biosciences and technology.
Dr. Ramos continues to guide the institute's strategic priorities in cancer research, infectious disease, drug discovery, and translational bioscience.